徐州彩超四维几个月去照(徐州专属医院 四维排畸预约) (今日更新中)

The vice presidential debate between Mike Pence and Kamala Harris next week will go on as scheduled after President Donald Trump, the First Lady, and others have tested positive for the coronavirus on Friday.An official with the Commission on Presidential Debates confirmed that no changes are anticipated to the Wednesday night debate in Salt Lake City. Both Pence and Harris underwent tests for the coronavirus on Friday and tested negative.Pence’s physician said in a memo that the vice president was not considered a “close contact” of anyone infected with COVID-19 and was not required to quarantine.“Vice President Mike Pence remains in good health and is free to go about his normal activities,” said Navy Lt. Commander Dr. Jesse Schonau in a statement.The one debate between the vice presidential candidates will take place Wednesday in Salt Lake City at the University of Utah. It will be moderated by Susan Page, the Washington Bureau Chief for USA Today. 974

The U.S. will pay drug company Pfizer .95 billion to produce and deliver 100 million doses of the company's COVID-19 vaccine candidate should the drug prove effective in human trials the company said in a press release on Wednesday.Pfizer will deliver the vaccine if and when the drug receives Emergency Use Authorization from the FDA after a large-scale Phase 3 trial.According to the reports, the deal includes an option for the government to purchase an additional 500 million doses of the vaccine.“Expanding Operation Warp Speed’s diverse portfolio by adding a vaccine from Pfizer and BioNTech increases the odds that we will have a safe, effective vaccine as soon as the end of this year,” Health and Human Services Sec. Alex Azar said in a statement. “Depending on success in clinical trials, today’s agreement will enable the delivery of approximately 100 million doses of this vaccine to the American people.”Pfizer and German firm BioNTech are working together to develop the vaccine.On Monday, Pfizer said in a press release that results from Phases 1 and 2 of a German trial indicated that the drug "could potentially be administered safely, with a manageable tolerability profile," according to data from the tests.Biotech company Moderna is also working to develop a coronavirus vaccine. That candidate will move into Phase 3 testing by the end of the month, and the government has also agreed to purchase and distribute the drug should the large-scale test prove effective. 1497

The US Supreme Court has ruled in favor of Black Lives Matter protest organizer Deray Mckesson.A Louisiana police officer had sued to hold Mckesson accountable for injuries the officer sustained in 2016 when he was hit by a heavy object.Mckesson didn't throw the object.The person who did is still unidentified.A lower court ruling had allowed the suit to move forward.Critics said the decision would dismantle the Civil Rights era precedent safeguarding the first amendment right to protest.The Supreme Court's decision wiped away the earlier ruling, sending the case back to the lower courts to further review Louisiana law.The justices ruled the case needed more guidance from state courts before important constitutional questions are considered. 758

The Supreme Court decided on Monday that they will not reexamine a doctrine that protects law enforcement and government officials from being sued over their actions while on the job.The doctrine, which the justices created nearly 50 years ago, gives "qualified immunity" for law enforcement officers, which protects them from frivolous lawsuits CNN reported.The decision comes amid protests over the death of George Floyd, who died while in police custody in Minneapolis.According to CBS News, the courts were to hear one case about a man in Tennessee that was bitten by a police dog, although he was sitting on the ground with his hands raised.NPR reports that two justices, Sonia Sotomayor and Clarence Thomas, have both been skeptical of the doctrine. 763

The United States is at the beginning of a second wave of significant job loss.“We are seeing a resurgence in layoffs that has been quite clearly indicated in the last couple of weeks,” said Daniel Alpert, an adjunct professor and senior fellow at Cornell University.Cornell University recently published a study showing about a third of the people who went back to work during the pandemic have now been laid off for a second time. Another 26 percent of workers have been warned by their employers that future furloughs and layoffs may soon come.“The problem is that you get an echo,” said Alpert. “So, if you have a resurgence in layoffs, a decrease in spending, that creates more contraction on the part of businesses, which creates more layoffs. The question is, when can you put a floor under this spiraling situation? It is a classic economic spiral.”The cycle--of job loss eventually leading to more job loss--is causing some to fear it could lead to a third wave of unemployment in a few months. Experts, like Alpert, believe the only way to stop the cycle would be a vaccine or for Congress to come together on another stimulus bill that props up households and businesses until a vaccine is released.“We are very concerned about the current rollercoaster effect on resumed layoffs, but longer term, we are really scared about seeing huge numbers, tens of millions of businesses vanish,” said Alpert.The more waves of unemployment we see, the higher likelihood of that. 1486

来源：资阳报